scispace - formally typeset
H

Howard C.B. Graves

Researcher at Stanford University

Publications -  11
Citations -  1312

Howard C.B. Graves is an academic researcher from Stanford University. The author has contributed to research in topics: Prostate-specific antigen & Prostate. The author has an hindex of 10, co-authored 11 publications receiving 1297 citations. Previous affiliations of Howard C.B. Graves include American Urological Association.

Papers
More filters
Journal ArticleDOI

Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.

TL;DR: It is speculated that PSA may serve to modulate IGF function within the reproductive system or in prostate cancer by altering IGF-IGFBP-3 interactions.
Journal ArticleDOI

Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard.

TL;DR: ISMS of PSA is proposed as a convenient and reliable method of quality control, an indispensible step towards international standardization of this very important tumor marker for detection and monitoring of prostatic diseases, especially prostate cancer.
Journal ArticleDOI

An Analysis of Urinary Prostate Specific Antigen Before and After Radical Prostatectomy: Evidence for Secretion of Prostate Specific Antigen by the Periurethral Glands

TL;DR: It is concluded that the first voided urine sample better reflects local PSA production by the prostate than the midstream sample, first Voided urine PSA decreases significantly in response to radical prostatectomy but is still present in measurable amounts even in surgically cured prostate cancer patients and urethral secretion of low levels of PSA persists after radical prostateCTomy.
Journal ArticleDOI

Comparison of a Polyclonal and Monoclonal Immunoassay for PSA: Need for an International Antigen Standard

TL;DR: Two leading commercial immunoassays for prostate specific antigen were compared using independently purified antigen as the calibrator, confirming that differences in assay values arise from differences in the assigned values of the kit calibrators.
Journal ArticleDOI

Early Detection of Residual Prostate Cancer After Radical Prostatectomy by an Ultrasensitive Assay for Prostate Specific Antigen

TL;DR: It is concluded that an ultrasensitive assay for PSA can detect residual cancer after radical prostatectomy much earlier than current immunoassays for PRA, to improve long-term survival by allowing for earlier institution of adjuvant therapy.